Search results
Fox News misinterprets results of study to blame millions of “excess deaths” on the COVID-19 vaccine
Media Matters· 2 days agoWritten by Helena Hind Published 06/13/24 9:21 AM EDT
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 6 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
Feeling rough after your COVID shot? That's a sign it's working
Medical Xpress· 5 days agoOne of the most common reasons for bypassing the COVID vaccine is concern about side effects like tiredness, muscle ...
Moderna to present combo COVID-flu vaccine to regulators after trial
Scripps News via AOL· 5 days ago19 vaccine. Moderna said the combination shot provided a more robust immune response than the...
Is There a New COVID Booster to Prevent Against FLiRT Variants?
Good Housekeeping· 6 days agoA lot has happened with COVID-19 vaccines in the past few years, making it difficult to keep up....
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 5 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine ...
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 5 days agoIt could also help Moderna offset declining demand for COVID-19 vaccines. “Combination vaccines have...
Moderna COVID/flu combo vaccine superior to separate shots in trial
Reuters via Yahoo News· 5 days agoModerna said on Monday its combination vaccine to protect against both COVID-19 and influenza...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
Morningstar· 2 days agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-< ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
The Kansas City Star· 2 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-< ...